Management of cardiovascular disease in aging persons with haemophilia

Hamostaseologie. 2017 Aug 7;37(3):196-201. doi: 10.5482/HAMO-16-09-0037. Epub 2016 Dec 14.

Abstract

With the aging of the haemophilia population, age related comorbidities become more and more a medical issue. Managing haemophilia patients with cardiovascular disease is a difficult task for many haemophilia-treating physicians. Over the years, insights on prevalence, risk factors and management of cardiovascular disease in haemophilia have improved substantially. It is now recognised that many risk factors, such as hypertension and overweight, occur quite frequently in patients with haemophilia. Several new insights in anticoagulation management of atrial fibrillation and coronary ischaemia in haemophilia have been suggested. This review provides an general overview of the current knowledge of these topics in literature.

Keywords: anticoagulation; cardiovascular; haemophilia.

Publication types

  • Review

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use
  • Atrial Fibrillation / blood
  • Atrial Fibrillation / complications
  • Atrial Fibrillation / epidemiology
  • Atrial Fibrillation / therapy
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / complications*
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / therapy*
  • Comorbidity
  • Coronary Artery Disease / blood
  • Coronary Artery Disease / complications
  • Coronary Artery Disease / epidemiology
  • Coronary Artery Disease / therapy
  • Cross-Sectional Studies
  • Factor IX / metabolism
  • Factor VIII / metabolism
  • Hemophilia A / blood
  • Hemophilia A / complications*
  • Hemophilia A / epidemiology
  • Hemophilia A / therapy*
  • Humans
  • Middle Aged
  • Myocardial Infarction / blood
  • Myocardial Infarction / complications
  • Myocardial Infarction / epidemiology
  • Myocardial Infarction / therapy
  • Risk Factors

Substances

  • Anticoagulants
  • F8 protein, human
  • Factor VIII
  • Factor IX